Loading…
Safety and immunogenicity of H5N1 vaccine
We believe that trials assessing new vaccines containing aluminium hydroxide adjuvant should include long-term follow-up of enrolled participants.
Saved in:
Published in: | The Lancet (British edition) 2006-12, Vol.368 (9554), p.2209-2210 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We believe that trials assessing new vaccines containing aluminium hydroxide adjuvant should include long-term follow-up of enrolled participants. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(06)69891-7 |